Step 2: Look at the ingredient list, not the name Always request the Certificate of Analysis (COA)
it cannot be legally prescribed in the UK outside of regulated clinical trials
Andreozzi F, Raciti GA, Nigro C, Mannino GC, Procopio T, Davalli AM, Beguinot F, Sesti G, Miele C, Folli F
Currently, the following drugs are approved for long-term treatment of obesity worldwide: Orlistat (Xenical, Xenical, Roche, Basel, Switzerland), 1999
Glucagon receptor agonism increases: Basal metabolic rate Thermogenesis (heat production from brown adipose tissue) Hepatic fat oxidation Fatty acid oxidation in skeletal muscle The key insight is that when glucagon receptor agonism is combined with GLP-1R agonism (which counters glucagon's glucose-raising effects), the net glycaemic outcome remains favourable while the metabolic-rate and fat-oxidation benefits of glucagon are preserved